Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01639924 · ClinicalTrials.gov registry record
Evaluation of People With Gastrointestinal Disease
A clinical trial of Gastrointestinal Diseases, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Completed
- Registry status
- 2,761
- Enrollment target
- 1
- Study location
NCT01639924: Completed study of Gastrointestinal Diseases, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
NCT01639924 is a study of Gastrointestinal Diseases that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 2,761 participants, below the 36,220-participant average among 14 other Gastrointestinal Diseases trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01639924, a study of Gastrointestinal Diseases, has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- COMPLETED
- Registry status
- 2,761 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: \- Gastrointestinal diseases and disorders affect the throat, stomach, and intestines. There are many different kinds of these diseases. Clinical trials are being developed to study new ways to treat them. People who are interested in clinical trials need to be screened before they can take part in the studies. Researchers want to evaluate people with different stomach and intestine disorders to see if they are eligible for clinical trials. Objectives: \- To study people who have gastrointestinal disorders and see if they are eligible for clinical trials. Eligibility: \- Individuals at least 18 years of age who have or may have a gastrointestinal disorder. Design: * Participants will be screened with a physical exam and medical history. Blood, urine, and stool samples will be collected. Imaging studies such as x-rays and ultrasound will check to see if the disorder has affected other organs. * Participants may have tests as needed depending on their disorder. These tests include the following: * Colonoscopy and endoscopy of the large intestine, esophagus, and stomach. * Stomach acid analysis to look at stomach pH levels. * Wireless capsule endoscopy to take pictures of the small intestine. * Hydrogen breath testing to study issues like bloating, diarrhea, and constipation. * Sitz Marker Study to see how fast stool moves through the colon. * Participants may donate extra blood, urine, or stool samples for study. They may also donate stomach contents or tissue from the gut. * Treatment will not be provided as part of this study. However, participants may be admitted to other clinical trials.
Primary Outcome
screening protocol for gastrointestinal diseases.
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,761 participants |
| Start Date | 2012-07-27 |
| Est. Completion | 2022-02-15 |
What the finished NCT01639924 record still lists
NCT01639924 is an observational study that tracks outcomes without assigning an intervention. Its 2,761 participants enrollment target places it among the larger protocols in the corpus, below the 36,220-participant average among 14 other Gastrointestinal Diseases trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Gastrointestinal Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT01639924 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT01639924 about?
NCT01639924 is a clinical study titled "Evaluation of People With Gastrointestinal Disease". Background: \- Gastrointestinal diseases and disorders affect the throat, stomach, and intestines. There are many different kinds of these diseases. Clinical trials are being developed to study new ways to treat them. People who are interested in clinical trials need to be screened before they can ...
What is the current status of trial NCT01639924?
This trial is currently completed. The enrollment target is 2,761 participants. The study started on 2012-07-27. Estimated completion is 2022-02-15.
What conditions does trial NCT01639924 study?
This clinical trial studies the following conditions: Gastrointestinal Diseases.
Who is sponsoring clinical trial NCT01639924?
This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01639924 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastrointestinal Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01639924's enrollment target sits among peer trials
2,761 3rd of 14 higher than 12 of 14 other Gastrointestinal Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gastrointestinal Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors
RECRUITING · Phase 1
-
Foregut Leaks-Role of Microbiome
RECRUITING · NA
-
Trans-nasal Endoscopy for Bariatric Patients
RECRUITING · NA
-
Evaluation of Patients With Gastrointestinal Disease
RECRUITING
-
Virtual Reality for Non-cardiac Chest Pain
RECRUITING · NA
-
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05443737 · 2,800 participants · Phase 3
Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients
- NCT05899439 · 2,800 participants
Immune Function and the Progression to T1D
- NCT06089109 · 2,800 participants · NA
Creating VIP Corps to Reduce Maternal Deaths
- NCT06345339 · 2,800 participants · Phase 2
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI